Radiation Oncology, Treatment Protocols
A Phase Ib Trial of Neoadjuvant AMG-232 Concurrent with Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)
Effective, February 21st, 2020, NRG DT001, Cohort B, is temporarily closed to accrual. Cohort B will remain closed for approximately 2 months until all patients complete the DLT evaluation period. Dose level 3 for Cohort A (extremity/body wall) will remain open to accrual.